Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 2, 1996, Pages 590-596

  Ooie, Tsuyoshi ^a   Suzuki, Hiroshi ^a   Terasaki, Tetsuya ^a   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CHOROID PLEXUS; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DISTRIBUTION; DRUG TRANSPORT; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LIPOPHILICITY; MALE; NONHUMAN; PRIORITY JOURNAL; TRANSPORT KINETICS;

ANIMALS; BRAIN; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; NORFLOXACIN; QUINOLONES; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0030425696     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ADKISON, K. D. K., ARTKU, A. A., POWERS, K. M. AND SHEN, D. D.: Contribution of probenecid-sensitive anion transport processes at the brain capillary endothelium and choroid plexus to the efficient efflux of valproic acid from the central nervous system. J. Pharmacol. Exp. Ther. 268: 797-805, 1994.
2. CHRIST, W.: Central nervous system toxicity of quinolones: Human and animal findings. J. Antimicrob. Chemother. 26: suppl. B, 219-225, 1990.
3. CORNFORD, E. M., DIEP, C. P., PAHDRIDGE, W. M.: Blood-brain barrier transport of valproic acid. J. Neurochem. 44:1541-1550, 1985.
4. DYKSTRA, K. H., ARYA, A., AHRIOLA, D. M., BUNGAY, P. M., MORRISON, P. F. AND DEDRICK, R. L.: Microdialysis study of zidovudine (AZT) transport in rat brain. J. Pharmacol. Exp. Ther. 267: 1227-1236, 1993.
5. FURET, Y. X., DESHUSSES, J. AND PECHÈRE, J. C.: Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36: 2506-2511, 1992.
6. GILFILLAN, E. C., PELAK, B. A., BLAND, J. A., MALATESTA, P. F. AND GADEBUSCH, H. H.: Pharmacokinetic studies of norfloxacin in laboratory animals. Chemotherapy 30: 288-296, 1984.
7. JAEHDE, U., GOTO, T., DE BOER, A. G. AND BREIMER, D. D.: Blood-brain barrier transport rate of quinolone antibacterials evaluated in cerebrovascular endothelial cell cultures. Eur. J. Phar. Sci. 1: 49-55, 1993.
8. JAEHDE, U., LANGEMEIJER, M. W. E., DE BOER, A. G. AND BREIMER, D. D.: Cerebrospinal fluid transport and disposition of the quinolones ciprofloxacin and pefloxacin in rats. J. Pharmacol. Exp. Ther. 263: 1140-1146, 1992.
9. KUSAJIMA, H., ISHIKAWA, N., MACHIDA, M., UCHIDA, H. AND IRIKURA, T.: Pharmacokinetics of a new quinolone, AM-833, in mice, rats, rabbits, dogs, and monkeys. Antimicrob. Agents Chemother. 30: 304-309, 1986.
10. LEVIN, V. A.: Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 23: 682-684, 1980.
11. MATSUSHITA, H., SUZUKI, H., SUGIYAMA, Y., SAWADA, Y., IGA, T., KAWAGUCHI, Y. AND HANANO, M.: Facilitated transport of cefodizime into the rat central nervous system. J. Pharmacol. Exp. Ther. 259: 620-625, 1991.
12. MONTAY, G., GOUEFFON, Y. AND ROQUET, F.: Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans. Antimicrob. Agents Chemother. 25: 463-472, 1984.
13. NEUMAN, M.: Clinical pharmacokinetics of the newer antibacterial 4-quinolones. Clin. Pharmacokinet. 14: 96-121, 1988.
14. NOHJOH, T., SUZUKI, H., SAWADA, Y., SUGIYAMA, Y., IGA, T. AND HANANO, M.: Transport of cefodizime, a novel third generation cephalosporin antibiotic, in isolated rat choroid plexus. J. Pharmacol. Exp. Ther. 250: 324-328, 1989.
15. OCHS, H. R., GREENBLATT, D. J., ABERNETHY, D. R., ARENDT, R. M., GERLOFF, J., EICHELKRAUT, W. AND HAHN, N.: Cerebrospinal fluid uptake and peripheral distribution of centrally acting drugs: Relation to lipid solubility. J. Pharm. Pharmacol. 37: 428-431, 1985.
16. OGAWA, M., SUZUKI, H., SAWADA, Y., HANANO, M. AND SUGIYAMA, Y.: Kinetics of active efflux via choroid plexus of β-lactam antibiotics from the CSF into the circulation. Am. J. Physiol. 266: R392-R399, 1994.
17. OKAZAKI, O., KURATA, T., HAKUSUI, H. AND TACHIZAWA, H.: Species-related stereoselective disposition of ofloxacin in the rat, dog and monkey. Xenobiotica 22: 439-450, 1992.
18. OOIE, T., SUZUKI, H., TERASAKI, T. AND SUGIYAMA, Y.: Characterization of the transport properties of a quinolone antibiotic, fleroxacin, in rat choroic plexus. Pharm. Res. 13: 512-516, 1996.
19. OOIE, T., SUZUKI, H., TERASAKI, T. AND SUGIYAMA, Y.: Kinetics of quinolone antibiotics in rats: Efflux from cerebrospinal fluid to the circulation. Pharm Res. in prees.
20. SCHINKEL, A. H., SMIT, J. J. M., TELLINGEN, O., BEIJNEN, J. H., WAGENAAR, E. DEEMTER, L., MOL, C. A. A. M., VALK, M. A., ROBANUS-MAANDAG, E. C., RIELE H. P. J., BERNS, A. J. M. AND BORST, P.: Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491-502, 1994.
21. SÖRGEL, F., JAEHDE, U., NABER, K. AND STEPHAN, U.: Pharmacokinetic disposition of quinolones in human body fluids and tissues. Clin. Pharmacokinet. 16: suppl. 1, 5-24, 1989.
22. SPECTOR, R.: Ceftriaxone pharmacokinetics in the central nervous system. J Pharmacol. Exp. Ther. 236: 380-383, 1986.
23. SUZUKI, H., SAWADA, Y., SUGIYAMA, Y., IGA, T. AND HANANO, M.: Traneport of cimetidine by the rat choroid plexus in vitro. J. Pharmacol. Exp. Ther. 239: 927-935, 1986.
24. SUZUKI, H., SAWADA, Y., SUGIYAMA, Y., IGA, T. AND HANANO, M.: Transport of benzylpenicillin by the rat choroid plexus in vitro. J. Pharmacol. Exp. Ther. 242: 660-665, 1987.
25. SUZUKI, H., SAWADA, Y., SUGIYAMA, Y., IGA, T., HANANO, M. AND SPECTOR, R.: Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system. J. Pharmacol. Exp. Ther. 250: 979-984, 1989.
26. TAGA, F., KOBAYASHI, F., SAITO, S., OOIE, T., KAWAHARA, F., UCHIDA, H., SHIMADA, J., HORI, S. AND SAKAI, O.: Possibility for induction of convulsion by fleroxacin and its disposition in the central nervous system in animals. Arzneim.-Forsch./Drug Res. 40: 900-904, 1990.
27. TATSUTA, T., NAITO, M., OH-HARA, T., SUGAWARA, I. AND TSURUO, T.: Functional involvement of P-glycoprotein in blood-brain barrier. J. Biol. Chem. 267: 20383-20391, 1992.
28. TSUJI, A., TERASAKI, T., TAKABATAKE, Y., TENDA, Y., TAMAI, I., YAMASHIMA, T., MORITANI, S., TSURUO, T. AND YAMASHITA, J.: P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci. 51:1427-1437, 1992.
29. WOLFSON, J. S. AND HOOPER, D. C.: Quinolone Antimicrobial Agents, American Society for Microbiology, Washington, DC, 1989.
30. YAMAOKA, K., TANIGAWARA, Y., NAKAGAWA, T. AND UNO, T.: A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4: 879-885, 1981.